Cargando…

Retraction Note: Dapagliflozin Guards Against Cadmium-Induced Cardiotoxicity via Modulation of IL6/STAT3 and TLR2/TNFα Signaling Pathways

Detalles Bibliográficos
Autores principales: Refaie, Marwa M. M., Rifaai, Rehab Ahmed, Fawzy, Michael Atef, Shehata, Sayed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10066064/
https://www.ncbi.nlm.nih.gov/pubmed/36857015
http://dx.doi.org/10.1007/s12012-023-09787-5
_version_ 1785018217962405888
author Refaie, Marwa M. M.
Rifaai, Rehab Ahmed
Fawzy, Michael Atef
Shehata, Sayed
author_facet Refaie, Marwa M. M.
Rifaai, Rehab Ahmed
Fawzy, Michael Atef
Shehata, Sayed
author_sort Refaie, Marwa M. M.
collection PubMed
description
format Online
Article
Text
id pubmed-10066064
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-100660642023-04-02 Retraction Note: Dapagliflozin Guards Against Cadmium-Induced Cardiotoxicity via Modulation of IL6/STAT3 and TLR2/TNFα Signaling Pathways Refaie, Marwa M. M. Rifaai, Rehab Ahmed Fawzy, Michael Atef Shehata, Sayed Cardiovasc Toxicol Retraction Note Springer US 2023-03-01 2023 /pmc/articles/PMC10066064/ /pubmed/36857015 http://dx.doi.org/10.1007/s12012-023-09787-5 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Retraction Note
Refaie, Marwa M. M.
Rifaai, Rehab Ahmed
Fawzy, Michael Atef
Shehata, Sayed
Retraction Note: Dapagliflozin Guards Against Cadmium-Induced Cardiotoxicity via Modulation of IL6/STAT3 and TLR2/TNFα Signaling Pathways
title Retraction Note: Dapagliflozin Guards Against Cadmium-Induced Cardiotoxicity via Modulation of IL6/STAT3 and TLR2/TNFα Signaling Pathways
title_full Retraction Note: Dapagliflozin Guards Against Cadmium-Induced Cardiotoxicity via Modulation of IL6/STAT3 and TLR2/TNFα Signaling Pathways
title_fullStr Retraction Note: Dapagliflozin Guards Against Cadmium-Induced Cardiotoxicity via Modulation of IL6/STAT3 and TLR2/TNFα Signaling Pathways
title_full_unstemmed Retraction Note: Dapagliflozin Guards Against Cadmium-Induced Cardiotoxicity via Modulation of IL6/STAT3 and TLR2/TNFα Signaling Pathways
title_short Retraction Note: Dapagliflozin Guards Against Cadmium-Induced Cardiotoxicity via Modulation of IL6/STAT3 and TLR2/TNFα Signaling Pathways
title_sort retraction note: dapagliflozin guards against cadmium-induced cardiotoxicity via modulation of il6/stat3 and tlr2/tnfα signaling pathways
topic Retraction Note
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10066064/
https://www.ncbi.nlm.nih.gov/pubmed/36857015
http://dx.doi.org/10.1007/s12012-023-09787-5
work_keys_str_mv AT refaiemarwamm retractionnotedapagliflozinguardsagainstcadmiuminducedcardiotoxicityviamodulationofil6stat3andtlr2tnfasignalingpathways
AT rifaairehabahmed retractionnotedapagliflozinguardsagainstcadmiuminducedcardiotoxicityviamodulationofil6stat3andtlr2tnfasignalingpathways
AT fawzymichaelatef retractionnotedapagliflozinguardsagainstcadmiuminducedcardiotoxicityviamodulationofil6stat3andtlr2tnfasignalingpathways
AT shehatasayed retractionnotedapagliflozinguardsagainstcadmiuminducedcardiotoxicityviamodulationofil6stat3andtlr2tnfasignalingpathways